annual CFF:
$480.49M+$335.10M(+230.49%)Summary
- As of today (May 29, 2025), ASND annual cash flow from financing activities is $480.49 million, with the most recent change of +$335.10 million (+230.49%) on December 31, 2024.
- During the last 3 years, ASND annual CFF has risen by +$64.73 million (+15.57%).
- ASND annual CFF is now -30.19% below its all-time high of $688.24 million, reached on December 31, 2020.
Performance
ASND Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
N/ASummary
- ASND quarterly cash flow from financing activities is not available.
Performance
ASND quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM CFF:
N/ASummary
- ASND TTM cash flow from financing activities is not available.
Performance
ASND TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ASND Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +230.5% | - | - |
| 3 y3 years | +15.6% | - | - |
| 5 y5 years | -13.1% | - | - |
ASND Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +230.5% | ||||
| 5 y | 5-year | -30.2% | +230.5% | ||||
| alltime | all time | -30.2% | >+9999.0% |
ASND Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $480.49M(+230.5%) | -$7.66M(-101.6%) | $480.49M(-0.0%) |
| Sep 2024 | - | $470.95M(<-9900.0%) | $480.72M(+189.8%) |
| Jun 2024 | - | -$2.82M(-114.1%) | $165.86M(-0.2%) |
| Mar 2024 | - | $20.01M(-369.6%) | $166.15M(+14.3%) |
| Dec 2023 | $145.39M(-65.3%) | -$7.42M(-104.8%) | $145.39M(-15.9%) |
| Sep 2023 | - | $156.09M(-6271.3%) | $172.90M(-2923.4%) |
| Jun 2023 | - | -$2.53M(+235.5%) | -$6.12M(-78.6%) |
| Mar 2023 | - | -$754.00K(-103.8%) | -$28.62M(-106.8%) |
| Dec 2022 | $418.44M(+0.6%) | $20.09M(-187.6%) | $418.43M(+11.4%) |
| Sep 2022 | - | -$22.94M(-8.4%) | $375.47M(-55.1%) |
| Jun 2022 | - | -$25.03M(-105.6%) | $835.33M(-3.1%) |
| Mar 2022 | - | $446.31M(-2051.1%) | $862.04M(+107.3%) |
| Dec 2021 | $415.75M(-39.6%) | -$22.87M(-105.2%) | $415.75M(-4.2%) |
| Sep 2021 | - | $436.93M(>+9900.0%) | $434.19M(-36.3%) |
| Jun 2021 | - | $1.68M(+6856.0%) | $681.50M(-1.2%) |
| Mar 2021 | - | $24.10K(-100.5%) | $689.50M(+0.2%) |
| Dec 2020 | $688.24M(+24.6%) | -$4.44M(-100.6%) | $688.24M(-1.8%) |
| Sep 2020 | - | $684.23M(+6968.6%) | $701.16M(+5019.4%) |
| Jun 2020 | - | $9.68M(-885.3%) | $13.70M(+91.4%) |
| Mar 2020 | - | -$1.23M(-114.5%) | $7.16M(-98.7%) |
| Dec 2019 | $552.58M | $8.48M(-362.4%) | $552.58M(+0.7%) |
| Sep 2019 | - | -$3.23M(-202.9%) | $548.84M(+0.1%) |
| Jun 2019 | - | $3.14M(-99.4%) | $548.22M(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $544.19M(>+9900.0%) | $542.31M(+125.9%) |
| Dec 2018 | $240.02M(+69.9%) | $4.74M(-223.1%) | $240.02M(-3.7%) |
| Sep 2018 | - | -$3.85M(+39.2%) | $249.21M(-34.4%) |
| Jun 2018 | - | -$2.77M(-101.1%) | $379.67M(-0.7%) |
| Mar 2018 | - | $241.90M(+1636.1%) | $382.46M(+170.8%) |
| Dec 2017 | $141.25M(+8.6%) | $13.93M(-89.0%) | $141.25M(-45.0%) |
| Sep 2017 | - | $126.61M(>+9900.0%) | $256.60M(+97.2%) |
| Jun 2017 | - | $22.50K(-96.7%) | $130.13M(-0.4%) |
| Mar 2017 | - | $686.00K(-99.5%) | $130.69M(+0.5%) |
| Dec 2016 | $130.00M(+10.8%) | $129.29M(>+9900.0%) | $130.00M(>+9900.0%) |
| Sep 2016 | - | $137.00K(-76.3%) | $541.60K(-88.2%) |
| Jun 2016 | - | $577.30K(>+9900.0%) | $4.58M(+57.5%) |
| Mar 2016 | - | $0.00(-100.0%) | $2.91M(-97.5%) |
| Dec 2015 | $117.34M(+84.2%) | -$172.70K(-104.1%) | $117.34M(-35.4%) |
| Sep 2015 | - | $4.18M(-481.5%) | $181.76M(+2.7%) |
| Jun 2015 | - | -$1.09M(-101.0%) | $177.05M(-0.6%) |
| Mar 2015 | - | $114.43M(+78.1%) | $178.14M(+179.6%) |
| Dec 2014 | $63.71M(<-9900.0%) | $64.24M(<-9900.0%) | $63.71M(<-9900.0%) |
| Sep 2014 | - | -$535.40K(<-9900.0%) | -$535.40K(<-9900.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00 | $0.00 |
| Dec 2013 | -$292.20K(+10.8%) | - | - |
| Dec 2012 | -$263.60K | - | - |
FAQ
- What is Ascendis Pharma A/S annual cash flow from financing activities?
- What is the all time high annual CFF for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual CFF year-on-year change?
- What is the all time high quarterly CFF for Ascendis Pharma A/S?
- What is the all time high TTM CFF for Ascendis Pharma A/S?
What is Ascendis Pharma A/S annual cash flow from financing activities?
The current annual CFF of ASND is $480.49M
What is the all time high annual CFF for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual cash flow from financing activities is $688.24M
What is Ascendis Pharma A/S annual CFF year-on-year change?
Over the past year, ASND annual cash flow from financing activities has changed by +$335.10M (+230.49%)
What is the all time high quarterly CFF for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly cash flow from financing activities is $684.23M
What is the all time high TTM CFF for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM cash flow from financing activities is $862.04M